Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent progress in alpha1-adrenergic receptor research.

Zhong-jian Chen1, Kenneth P Minneman

  • 1Department of Pharmacology, School of Medicine, Emory University, Atlanta, GA 30322, USA.

Acta Pharmacologica Sinica
|October 18, 2005
PubMed
Summary

New alpha1B-AR selective antagonists, like conopeptide rho-TIA, are crucial for understanding alpha1-adrenergic receptor (AR) functions. Studies in mice and investigations into receptor interactions are clarifying the roles of these important cardiovascular and brain receptors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Report of <i>Fusarium oxysporum</i> Causing Root Rot on <i>Salvia yunnanensis</i> in China.

Plant disease·2025
Same author

Large-scale separation of alkaloids from Corydalis decumbens by pH-zone-refining centrifugal partition chromatography and their anticomplement activity.

Journal of separation science·2023
Same author

Identification of Metabolomic Biomarkers of Seed Vigor and Aging in Hybrid Rice.

Rice (New York, N.Y.)·2022
Same author

miR-144-3p Contributes to the Development of Thyroid Tumors Through the PTEN/PI3K/AKT Pathway.

Cancer management and research·2020
Same author

Comparative genomic and transcriptomic analyses of chemosensory genes in the citrus fruit fly Bactrocera (Tetradacus) minax.

Scientific reports·2020
Same author

SMRT- and Illumina-based RNA-seq analyses unveil the ginsinoside biosynthesis and transcriptomic complexity in Panax notoginseng.

Scientific reports·2020

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cardiovascular Physiology

Background:

  • Alpha1-adrenergic receptors (AR) are key regulators of physiological processes, particularly in the cardiovascular system, mediated by norepinephrine and epinephrine.
  • The three subtypes (alpha1A, alpha1B, and alpha1D) are G protein-coupled receptors signaling via Gq/11, but their distinct functions remain unclear due to a lack of subtype-selective drugs.

Purpose of the Study:

  • To highlight the importance of developing subtype-specific drugs for alpha1-ARs to clarify the functional roles of individual subtypes.
  • To review recent advancements in understanding alpha1-AR functions in vivo and through molecular interactions.

Main Methods:

  • Identification of conopeptide rho-TIA as a novel alpha1B-AR selective antagonist with distinct inhibition mechanisms.

Related Experiment Videos

  • Analysis of studies using genetically engineered mice to investigate in vivo alpha1-AR functions.
  • Examination of protein interactions and receptor heterodimerization affecting alpha1-AR function, cell surface expression, signaling, and internalization.

    • Main Results:

    • Conopeptide rho-TIA exhibits selectivity for the alpha1B-AR subtype.
    • Genetically engineered mouse models provide in vivo insights into alpha1-AR roles, especially in the cardiovascular system and brain.
    • Receptor-protein interactions and heterodimerization are identified as critical regulators of alpha1-AR activity.

    Conclusions:

    • The development of subtype-specific drugs is essential for delineating the precise functions of alpha1-AR subtypes.
    • Emerging data from pharmacological tools, in vivo models, and molecular studies are advancing the understanding of alpha1-ARs.
    • These findings pave the way for a clearer elucidation of the specific physiological roles of each alpha1-AR subtype.